INTRODUCTION
============

Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis, with an estimated annual incidence of 3-10 cases per million in the population.^[@r1]^ It can present itself as a primary disorder or be associated with an underlying disease, particularly inflammatory bowel disease (IBD), arthritis, hematologic diseases, and malignant diseases.^[@r2]^

Typical clinical presentation consists of a pustule or nodule that evolves into a painful ulcer with an undermined and well-defined erythematous-violaceous border. The base of the ulcer commonly has granulation tissue with purulent or sanguinous exudate. It is usually located on lower limbs and displays centrifugal growth. Other possible forms of presentation include vegetative, bullous, and pustular types.

Its frequent association with autoimmune diseases and pathergy corroborate the hypothesis of PG as an autoimmune disease.^[@r3]^ Pathergy, which occurs in about 30% of cases, consists of the appearance of new lesions or the worsening of pre-existing lesions after a local trauma.^[@r4]^

The diagnosis is made - in addition to its compatible clinical characteristics - by excluding other causes of similar-appearing cutaneous ulcerations - including infection, malignancy, and vasculitis - by histopathological examination and laboratory study.

The treatment of secondary PG should consider the treatment of the underlying disease. In primary PG, corticosteroid therapy is the gold standard, sometimes in combination with immunosuppressant therapy.^[@r5]^

This paper aims to discuss an exuberant case of PG in a young patient with autoimmune hepatitis (AIH), emphasizing corticosteroid therapy management and the importance of local treatment.

CASE REPORT
===========

We report a 25-year-old female patient with recurrent ulcers on the lower limbs for the past four years. She reported onset with pustules, which progressed to ulceration in the left medial malleolus region. Later, she noticed other similar ulcers on both lower limbs, with disabling local pain. As a relevant medical record, she had type 1 AIH. She was on prednisone (20 mg daily) and azathioprine (100 mg daily) - precribed for AIH - and clobetasol cream 0.05%.

Physical examination revealed a deep ulcerated lesion on the lateral side of the right lower limb (RLL), about 5 cm in diameter, reaching the subcutaneous tissue, with violaceous regular and undermined edges, and base with purulent exudate and granulation tissue. We also observed two other ulcerated lesions on the lateral side of the RLL and an ulcer on the medial side of the RLL with similar characteristics ([Figure 1](#f1){ref-type="fig"}). Similar ulcers were observed in the anterior aspect of the left lower limb (LLL) and the medial aspect of the LLL - the latter particularly deep, with maceration on the edges and smaller adjacent ulceration. A total of seven ulcers were observed ([Figure 2](#f2){ref-type="fig"}).

Figure 1Right lower limb: aspect before treatment. Three deep ulcers on the lateral aspect and an ulcer in the medial region of the limb reaching the subcutaneous tissue, with violaceous regular and undermined edges

Figure 2Left lower limb: aspect before treatment. On the left, deep ulcer with violaceous irregular and macerated edges in left medial malleolus region, with smaller adjacent ulceration. On the right, ulcer on the anteromedial aspect of the limb. We also observed atrophic scars caused by previous ulcers.

Histopathological study of a lesion revealed unspecific, ulcerated, and chronic inflammation process ([Figures 3](#f3){ref-type="fig"} and [4](#f4){ref-type="fig"}). The search for mycobacteria, fungi, and sporotrichosis serology were negative. PCR for leishmaniasis and leishmanin skin test were also negative. Laboratory tests revealed elevated C-reactive protein, glucose intolerance, and normal liver laboratory tests, except for the elevation of gamma-glutamyltransferase.

Figure 3Histopathology. Ulcerated area with granulation tissue, recent hemorrhage, perivascular mononuclear inflammatory infiltrate and fibrosis (Hematoxylin & eosin x40)

Figure 4Histopathology. Histological detail showing inflammatory infiltrate composed of lymphocytes arranged around vessels (Hematoxylin & eosin x100)

We started treatment with prednisone at a dose of 70 mg/daily (1 mg/kg/day). In the first week, we used dressings with silver sulfadiazine 1% on the lesions. From the second week, we used dressings with carboxymethyl cellulose 3% gel and Nystatin ointment with zinc oxide - the latter only on the macerated edge of the ulcer in the left medial malleolus region (candidiasis associated). We recommended resting and keeping the lower limbs elevated.

The patient was discharged after 18 days of hospitalization, with the prescription of prednisone (60 mg/daily) and daily dressings as described above, as well as guidance to rest and elevate the lower limbs. Initially, we programmed the reduction of Prednisone by 10 mg per month. The patient returned a month after discharge showing healing process in the ulcers ([Figure 5](#f5){ref-type="fig"}). Two months after discharge, the seven ulcers were completely resolved with use of prednisone 40 mg/daily. Three months after discharge, we still observed the complete healing of ulcers with prednisone 30 mg/daily and emollient. At the time, we reduced the prednisone dose to 20 mg/daily and kept emollient topical care ([Figure 6](#f6){ref-type="fig"}).

Figure 5One month after the initiation of treatment. Healing ulcers on the right (A) and left (B) lower limbs. Re-epithelialization occurs from the edges of the lesion

Figure 6Three months after initiation of treatment. Complete healing of ulcers on the lateral aspect of the right lower limb

DISCUSSION
==========

Pyoderma gangrenosum (PG) is a rare dermatosis, and its association with autoimmune hepatitis (AIH) was rarely described in the literature. We report a case with torpid evolution, presenting with multiple and deep ulcers in a young patient with autoimmune hepatitis, causing pain and significant disability. Although the patient was treated with prednisone and azathioprine - both prescribed for AIH - the lesions showed no clinical improvement. In the present case, PG and the underlying disease did not follow parallel clinical courses, since AIH was inactive. It is known that the course of the PG can be parallel or not parallel in cases associated with underlying IBD.^[@r6]^

The systemic corticosteroid therapy is the treatment of choice for PG. High initial doses are often necessary, such as prednisone 60-80 mg/daily.^[@r7]^ In the present case, we initially prescribed prednisone 1 mg/kg/daily, an equivalent to 70 mg/daily. There are reports on the successful use of azathioprine for PG treatment, but they still require further scientific evidence.^[@r8]^ We believe that the importance given to local treatment was essential for the healing of the lesions. In this particular case, we applied silver sulfadiazine topical 1%, given the large amount of purulent exudate. Although it may be sterile in PG, we suspected secondary infection, considering the recent worsening of the lesion and the increased pain reported by the patient. Then we used carboxymethyl cellulose gel 3%, one of the components of the hydrogel dressing, which has healing properties by aiding cell rehydration and autolytic debridement.^[@r9]^ Because of the high cost of commercial hydrogel dressing, we chose to use isolated carboxymethyl cellulose.

We further emphasize the slow withdrawal of corticosteroid therapy: after 17 days using 1 mg/kg/daily, given the evolutionary improvement observed, we started to reduce by 10 mg every month; after 30 mg/daily, we reduced 10 mg every 15 days. We highlight the surprisingly satisfactory response to treatment, with complete healing of the lesions within two months. Currently, the patient is on prednisone 20 mg/daily without remission. However, long-term follow up is necessary, given the variable course of PG.^[@r10]^
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